Small molecule recognition of c-Src via the Imatinib-binding conformation.
Dar, A.C., Lopez, M.S., Shokat, K.M.(2008) Chem Biol 15: 1015-1022
- PubMed: 18940662 
- DOI: 10.1016/j.chembiol.2008.09.007
- Primary Citation of Related Structures:  
3EL7, 3EL8 - PubMed Abstract: 
The cancer drug, Imatinib, is a selective Abl kinase inhibitor that does not inhibit the closely related kinase c-Src. This one drug and its ability to selectively inhibit Abl over c-Src has been a guiding principle in virtually all kinase drug discovery efforts in the last 15 years ...